Disposition of Phencyclidine after Intramuscular Administration

  • A. Chari-Bitron
  • H. Edery
  • R. Chen
  • L. Motola
Conference paper
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 6)

Abstract

The disposition of radioactive phencyclidine (PCP) in various rat tissues, after single or repeated intramuscular injections for 23 days, have been investigated. Peak levels of radioactivity appeared 45–90 min after a single administration. The pancreas, salivary glands and mesenteric fat contained 4 to 6-fold higher radioactivity than brain, muscles, tendons, and bones. After repeated 3H-PCP injections, radioactivity levels showed a similar pattern as to that of the peak levels after a single administration, but at notably higher values. On the other hand, the percentage of depletion, within 48 h after the final injection, was the highest in the pancreas, salivary glands and mesenteric fat. It is possible that despite the low retention capacity of PCP radioactivity per unit weight of muscle, tendon and bone, they may be considered important reservoirs for either PCP, or its metabolites or both because of their large relative mass in the body.

Key words

Phencyclidine (PCP) disposition Intramuscular PCP Repeated PCP administration 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bailey DN, Shaw RF, Robinson PT (1979) Phencyclidine studies of tissue concentrations in the rat, monkey and man. J Anal Toxicol 3: 235–237Google Scholar
  2. Carlson KA (1979) PCP from the other side: users look at phencyclidine. J Psychoactive Drugs 11: 231–238Google Scholar
  3. Chari-Bitron A, Simon GA, Kadar T, Motola L (1979) Whole body autoradiography of 3H-phencyclidine in mice. Arch Toxicol 43: 85–92PubMedCrossRefGoogle Scholar
  4. James SH, Schnoll SH (1976) Phencyclidine: tissue distribution in the rat. Clin Toxicol 9: 537–582CrossRefGoogle Scholar
  5. Law FCP (1981) Metabolic disposition and irreversible binding of phencyclidine in rats. Toxicol Appl Pharmacol 57: 263–272PubMedCrossRefGoogle Scholar
  6. Martin BB, Vincek WC, Balster RL (1980) Studies of the disposition of phencyclidine in mice. Drug Metab Disp 8: 49–54Google Scholar
  7. Misra AL, Pontani RB, Bartholomew JG (1980) Disposition of 3H-phencyclidine in the rat after single and multiple doses. Life Sci 27: 2501–2508PubMedCrossRefGoogle Scholar
  8. Siegel RK (1978) Phencyclidine and ketamine intoxication. A study of four population of recreational users. In: Petersen RC, Stillman RC (eds) Phencyclidine abuse: Appraisal. NIDA Res Monogr 21: 119–147Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • A. Chari-Bitron
    • 1
  • H. Edery
    • 1
  • R. Chen
    • 1
  • L. Motola
    • 1
  1. 1.Israel Institute for Biological Research, Sackler School of MedicineTel-Aviv UniversityNess-ZionaIsrael

Personalised recommendations